Tumor samples from HER2-PDX and HER2-PDXR treated tumors showed an increased apoptosis compared with HER2-PDX and HER2-PDXR control tumors, assessed by fluorescent TUNEL assay (Figs 4B and 5B). Here, ERBB2 is linked to neoplasm.